Press
WISE s.r.l. raises € 1 M in equity financing to Develop Next-Generation Neurostimulation Devices
WISE (Wiringless Implantable Stretchable Electronics), a Milan- and Berlin-based medical device company is developing next-generation implantable neurostimulation devices based on their unique and proprietary technology platform. The company has now raised a seed-round of € 1 M to advance the development of its first product aimed at the spinal cord stimulation market. High-Tech Gründerfonds, Atlante Seeds and b-to-v Partners co-led the round and were joined by the existing investor Agite!.
Press
MedTech Radar Live 2019: Industry meets start-ups
Save the date: Second joint event organized by BVMed, Earlybird, BARMER, High-Tech Gründerfonds and Medtech Zwo on June 5th 2019 in Berlin
The second "MedTech Radar Live" event by BVMed, Earlybird, BARMER, High-Tech Gründerfonds and Medtech Zwo will take place on June 5th, 2019 in Berlin. Medical technology founders are brought together with medical device companies, health insurances and investors. In addition to a start-up pitch, there will be an exhibition and an expanded conference progra
Press
VMRay closes $10 million Series B round
Digital⁺ Partners Leads New Funding Round in Growing Automated Malware Analysis & Detection Provider to Combat Latest Advanced Threats and Support Market Expansion
VMRay, a provider of automated malware analysis and detection solutions, today announced that it has closed its series B round of funding in the amount of $10 million (€9 million) led by Digital⁺ Partners, one of the leading technology growth equity firms in Europe, and supplemented eCAPITAL, an early investor. This brings
Press
WISE S.r.l. raises EUR 3 million for clinical development of novel neuromodulation implants for spinal cord stimulation
Foldable and stretchable electrodes for growing neuromodulation market being developed
WISE Srl, a medical device company developing next-generation implantable neuromodulation leads announces today the closing of a EUR 3 million series A financing round, led by Principia SGR, an Italian Venture Capital firm. Existing investors High-Tech Gründerfonds, Atlante Seed and b-to-v Partners joined the round alongside with three new investors Atlante Ventures, F3F and Antares.
WISE develops novel, h
Press
Immunic successfully closes 17.5 million Euro Series A financing round
Immunic AG (Immunic), a recently formed private start-up biotech company in Planegg-Martinsried near Munich, Germany, today announced that it has closed its Series A financing round totaling EUR 17.5 million of preferred stock financing. The financing round was led by Life Sciences Partners V Coöperatief U.A. (LSP, The Netherlands) and LifeCare Partners (LCP, Switzerland). Further participating investors were Bayern Kapital (Landshut, Germany), High-Tech Gründerfonds (HTGF, Bonn, Germany) and
Press
Hematris – Specialist in blood clotting – attracts new investors
Aurelia Private Equity and KfW, the bank for medium-sized companies, are investing 2.0 million EUR in Hematris Wound Care. An investment for getting Hematrix® onto the market.
Hematris Wound Care GmbH has developed a unique wound patch, the “active“ patch Hematrix®. This patch stops the most severe, even arterial injury-related bleeding and external bleeding caused by surgical intervention in just a few minutes. The biodegradable patch is coated with blood-clotting components.
Hematr
Press
Target Partners and HTGF provide multimillion financing for Quobyte
Target Partners (www.targetpartners.de) and High-Tech Gründerfonds (HTGF) have invested a seven-figure Euro amount in Quobyte Inc. in a Series A financing round (www.quobyte.com). Quobyte is headquartered in Boston (USA) with R&D in Berlin. Quobyte develops and markets the Quobyte Unified Storage Plane (USP), a software-defined storage system that runs on commodity Linux servers. Quobyte USP enables customers to build cloud infrastructures with a quality equal to the big cloud providers suc
Press
Atriva reaches a development milestone and receives an additional tranche of running seed financing to develop its influenza therapeutic to clinical stage
The next generation of Antiviral Therapies: Co-Led by Stichting Participatie Atriva and High-Tech Gründerfonds (HTGF), Atriva Therapeutics GmbH has received a second tranche of its running seed financing in total of € 3 Mn from Dutch, German and Canadian investors, after lead compound ATR-002 (Atriva’s antiviral MEK-Inhibitor against Influenza) has passed an important preclinical milestone paving the way to clinical development stage.
Atriva Therapeutics stands for the next generation of
Press
Coredinate secures follow-on financing
New investor MWN Equity Investment and Bayern Kapital Innovationsfonds ERFE take stake
Coredinate, a software-as-a-service (Saas) company based in Uffenheim, Bavaria, has successfully closed a €1.9 million financing round. Alongside existing investors such as High-Tech Gründerfonds, Bayern Kapital has invested in the firm once again – this time using funds from its innovation fund BayernKapital Innovationsfonds ERFE, which replaces SeedFonds Bayern, the vehicle used for its previous inve
Coredinate secures follow-on financing
Press
EcoIntense Announces €22 million Growth Capital Investment from One Peak Partners and Morgan Stanley Expansion Capital
EcoIntense GmbH today announced the completion of a €22 million investment from private equity firm One Peak Partners and investment funds managed by Morgan Stanley Expansion Capital, the growth-focused private investment team within Morgan Stanley Investment Management. The funding will be primarily used to invest in the company’s international growth trajectory and product development.
EcoIntense is one of Europe’s leading software providers for health and safety, environmental manage
Event
EY Startup Academy
On September 15, 2022 the EY Startup Academy will begin with a kickoff event in Frankfurt. Together with strong cooperation partners, the EY Academy is looking for ambitious tech and FinTech business models with future potential for the 6th time. At the kick-off event, the most talented founders will present their business ideas at a pitch contest. At the end of the event, a jury of experts selects the finalists for the 6-week Start-up Academy program. There, the startups have the chance to impr
Press
A powerful motor for innovation and the economy: High-Tech Gründerfonds makes its 500th investment
• Together with co-investor Thüga, HTGF is investing a 7-figure sum
• The 500th startup in the HTGF portfolio is machine-learning company Geospin
Shortly after the successful second closing of the third fond and the IPO of NFON – the first flotation in the portfolio – High-Tech Gründerfonds (HTGF) and Thüga AG are making their 500th investment: Geospin develops software solutions for analysing geodata and, just two years after spinning-off from the Albert-Ludwigs University in Fre
Press
HTGF Invests in Groundbreaking Innovation for Pain Therapy by Dolosys GmbH
Dolosys GmbH, a young spin-off of the Charité Department of Anaesthesiology and Intensive Care Medicine, receives financing from High-Tech Gründerfonds (HTGF) and m2f investment Ltd. The Berlin start-up has developed a pain monitor, which can optimize pain therapy for sedated intensive care patients and patients with chronic pain. Dolosys GmbH is going to use the seed investment to complete the development of the pain monitor and to market it after its successful certification as a medical dev
Elisabeth Zlatkin – Junior Analyst
Elisabeth recently completed her MSc in Management at Imperial College London, specialising in Finance and building a solid foundation in venture capital’s financial and strategic aspects. She also founded Imperial Elevate, Imperial College’s first startup coaching initiative, focusing on emerging companies in healthtech and fintech. She scaled to a total of 30 business school mentors, 6 active startups, receiving official recognition from Imperial College Business School as an IB student association.
Elisabeth’s academic background includes a BA in Digital Media and Culture from King’s College London, where she developed strong analytical skills and a deep understanding of emerging technologies. Her passion for venture capital stems from the intersection of her interests in finance, technology, and business, making her a dedicated and insightful analyst in the tech investment space.